Literature DB >> 24089398

Nicotinic receptors regulate the dynamic range of dopamine release in vivo.

Jessica L Koranda1, Jackson J Cone, Daniel S McGehee, Mitchell F Roitman, Jeff A Beeler, Xiaoxi Zhuang.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are expressed presynaptically on dopamine axon terminals, and their activation by endogenous acetylcholine from striatal cholinergic interneurons enhances dopamine release both independently of and in concert with dopamine neuron activity. Acute nAChR inactivation is believed to enhance the contrast between low- and high-frequency dopamine cell activity. Although these studies reveal a key role for acute activation and inactivation of nAChRs in striatal microcircuitry, it remains unknown if chronic inactivation/desensitization of nAChRs can alter dopamine release dynamics. Using in vivo cyclic voltammetry in anaesthetized mice, we examined whether chronic inactivation of nAChRs modulates dopamine release across a parametric range of stimulation, varying both frequency and pulse number. Deletion of β2*nAChRs and chronic nicotine exposure greatly diminished dopamine release across the entire range of stimulation parameters. In addition, we observed a facilitation of dopamine release at low frequency and pulse number in wild-type mice that is absent in the β2* knockout and chronic nicotine mice. These data suggest that deletion or chronic desensitization of nAChRs reduces the dynamic range of dopamine release in response to dopamine cell activity, decreasing rather than increasing contrast between high and low dopamine activity.

Entities:  

Keywords:  chronic nicotine; dopamine release; dorsolateral striatum; in vivo cyclic voltammetry; β2 nicotinic subunit

Mesh:

Substances:

Year:  2013        PMID: 24089398      PMCID: PMC3921376          DOI: 10.1152/jn.00269.2013

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  86 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

2.  Dopamine-dependent motor learning: insight into levodopa's long-duration response.

Authors:  Jeff A Beeler; Zhen Fang Huang Cao; Mazen A Kheirbek; Yunmin Ding; Jessica Koranda; Mari Murakami; Un Jung Kang; Xiaoxi Zhuang
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

Review 3.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

4.  Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment.

Authors:  Sarah E McCallum; Neeraja Parameswaran; Tanuja Bordia; Hong Fan; Rachel F Tyndale; J William Langston; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

5.  Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain.

Authors:  Michael J Marks; Tristan D McClure-Begley; Paul Whiteaker; Outi Salminen; Robert W B Brown; John Cooper; Allan C Collins; Jon M Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  2011-01-12       Impact factor: 4.030

6.  Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice.

Authors:  C J Meliska; A Bartke; G McGlacken; R A Jensen
Journal:  Pharmacol Biochem Behav       Date:  1995-04       Impact factor: 3.533

Review 7.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

8.  Frequency-dependent modulation of dopamine release by nicotine.

Authors:  Hui Zhang; David Sulzer
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

9.  Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.

Authors:  Tianxiang Zhang; Lifen Zhang; Yong Liang; Athanassios G Siapas; Fu-Ming Zhou; John A Dani
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

10.  Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons.

Authors:  Sarah Threlfell; Tatjana Lalic; Nicola J Platt; Katie A Jennings; Karl Deisseroth; Stephanie J Cragg
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

View more
  25 in total

1.  Interactions between insulin and diet on striatal dopamine uptake kinetics in rodent brain slices.

Authors:  Jyoti C Patel; Melissa A Stouffer; Maria Mancini; Charles Nicholson; Kenneth D Carr; Margaret E Rice
Journal:  Eur J Neurosci       Date:  2018-08-01       Impact factor: 3.386

Review 2.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

3.  Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus.

Authors:  Cheng Xiao; Julie M Miwa; Brandon J Henderson; Ying Wang; Purnima Deshpande; Sheri L McKinney; Henry A Lester
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

4.  Multiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.

Authors:  Yann S Mineur; Gianna M Fote; Sam Blakeman; Emma L M Cahuzac; Sylvia A Newbold; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

Review 5.  Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.

Authors:  Eva Schaeffer; Andrea Pilotto; Daniela Berg
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

Review 6.  The striatal cholinergic system in L-dopa-induced dyskinesias.

Authors:  X A Perez; T Bordia; M Quik
Journal:  J Neural Transm (Vienna)       Date:  2018-02-28       Impact factor: 3.575

7.  Chronic Nicotine Mitigates Aberrant Inhibitory Motor Learning Induced by Motor Experience under Dopamine Deficiency.

Authors:  Jessica L Koranda; Anne C Krok; Jian Xu; Anis Contractor; Daniel S McGehee; Jeff A Beeler; Xiaoxi Zhuang
Journal:  J Neurosci       Date:  2016-05-11       Impact factor: 6.167

8.  Chronic Nicotine Alters Corticostriatal Plasticity in the Striatopallidal Pathway Mediated By NR2B-Containing Silent Synapses.

Authors:  Jianxun Xia; Allison M Meyers; Jeff A Beeler
Journal:  Neuropsychopharmacology       Date:  2017-05-02       Impact factor: 7.853

9.  The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway.

Authors:  Nii A Addy; Eric J Nunes; Shannon M Hughley; Keri M Small; Sarah J Baracz; Joshua L Haight; Anjali M Rajadhyaksha
Journal:  Neuropsychopharmacology       Date:  2018-05-03       Impact factor: 7.853

Review 10.  Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.

Authors:  Steven J Simmons; Thomas J Gould
Journal:  J Clin Pharm Ther       Date:  2014-05-14       Impact factor: 2.512

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.